The cardiac troponin market was valued at USD 3.51 Billion in 2025 and is expected to grow at a CAGR of 8.20%, reaching USD 7.72 Billion by 2035. The market growth is driven by increasing prevalence of cardiovascular diseases and demand for accurate cardiac biomarker diagnostics.
Base Year
Historical Period
Forecast Period
Compound Annual Growth Rate
8.2%
Value in USD Billion
2026-2035
*this image is indicative*
North America is anticipated to dominate the global cardiac troponin industry in the forecast period. Heart failure is a critical healthcare issue in the United States. It is highly prevalent and has high mortality and morbidity rate. The cost of care for heart diseases is high in the United States. The prevalence of heart failure in the country is expected to increase with an increasingly ageing population, driving the market growth in the region.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market is also growing due to high expenditure on research and development, major players and their product availability, and the well-established healthcare infrastructure in the region. The increase aids the demand for cardiac biomarkers for cardiovascular disease diagnosis, a rise in the incidence of the acute coronary syndrome (ACS), advancements in the treatment, and growth in demand for point-of-care cardiac testing kits. The key market players' high specificity and sensitivity of these markers to detect cardiac disorders also contribute to the market growth.
Troponin, a key regulatory protein of striated muscle's thin filament (actin), comprises three subunits: C, T, and I. Cardiovascular troponins are biomarkers or diagnostic markers used to detect myocardial infarction. Cardiac troponin is found in both skeletal and cardiac muscles, and a rise in cardiac troponin levels in the blood indicates the onset of myocardial infarction.
Breakup by Type
Breakup by Site of Testing
Breakup by Application
Breakup by End-Use
Breakup by Distribution Channel
Breakup by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global cardiac troponin industry is driven by the rising demand for cardiac biomarkers to diagnose cardiovascular diseases, the increasing prevalence of acute coronary syndrome, and the reduction in the burden of healthcare costs due to faster and acute diagnosis. Patients suffering from acute critical heart conditions require immediate results and quick diagnosis to avoid any causalities. Hence, physicians and doctors demand advanced use of cardiac troponins, pushing researchers and major companies to make investments. Major companies are focusing on the research and development of cardiac troponin tests and are aiming for the approval of new products to retain and enhance market competitiveness. For instance, in June 2018, Beckman Coulter Diagnostics received Health Canada clearance for its new high sensitivity troponin (hsTnI) assay, Access hsTnI, that aids in diagnosing myocardial infarction for patients presenting with chest pain or other ischemic symptoms.
Besides this, rising awareness among patients and healthcare providers about the importance of early diagnosis of various CVDs is driving the demand for these markers. An increase in the geriatric population and a rise in the number of patients suffering from heart attacks and chest pain due to lifestyle changes are expected to drive the market in the coming years.
The report gives a detailed analysis of the following key players in the global cardiac troponin industry, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
Upto 15% Off
USD
$3299 $2969
$5499 $4949
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The global cardiac troponin market will grow at a CAGR of 8.20% between 2026 and 2035.
The major drivers of the market include the reduction in the burden of healthcare costs, increasing investments, growing research and development activities, approval of new products, rising awareness among patients and healthcare providers, increase in the geriatric population, rise in the number of patients suffering from heart attacks and chest pain, and changes in lifestyles.
The rising demand for cardiac biomarkers to diagnose cardiovascular diseases and the increasing prevalence of acute coronary syndrome are the key industry trends propelling the market's growth.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Troponin T and troponin I are the different types of cardiac troponins in the market.
Based on the testing site, the market is divided into laboratory testing and point-of-care testing.
The major applications of the market are acute coronary syndrome, myocardial infarction, and congestive heart failure, among others.
The end-uses of the market include hospitals, diagnostic centres, and homecare settings, among others.
The several distribution channels of the market are manufacturer/ distributor/ service provider and aftermarket.
The major players in the industry are Abbott Laboratories, F. Hoffmann-La Roche Ltd, Siemens Healthcare GmbH, Eurolyser Diagnostica GmbH, and Beckman Coulter, Inc., among others.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Site of Testing |
|
| Breakup by Application |
|
| Breakup by End-Use |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share